The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: A meta-analysis of 20 populations

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 1, 2011, Pages 81-85

  Zhang, Lou Qian ^a   Huang, Xin En ^b   Wang, Jun ^c   Shang, Jun Qing ^b   Bai, Jianling ^a   Liu, Fu Yin ^c   Guan, Xin ^b   Zhou, Jian Nong ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c Geriatric Institution of Jiangsu Province   (China)

Author keywords

Colorectal cancer; CyclinD1; Meta analysis; Polymorphism

Indexed keywords

EID: 79958739979     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bala S, Peltomaki P. (2001). CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res, 61, 6042-5
2. Cochran W. (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29
3. DerSimonian R and Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88
4. Donnellan R, Chetty R. (1998). Cyclin D1 and human neoplasia. Mol Pathol, 51, 1-7
5. Egger M, Davey Smith G, Schneider M, et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34
6. Forones NM, de Lima JM, de Souza LG, et al. (2008). Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J Gastrointest Cancer, 39, 118-23
7. Grieu F, Malaney S, Ward R, et al. (2003). Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res, 23, 4257-9
8. Grunhage F, Jungck M, Lamberti C, et al. (2008). Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis, 23, 147-54
9. Guo SW, Thompson EA. (1992). Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 48, 361-72
10. Hall M, Peters G. (1996). Genetic alterations of cyclins, cyclindependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res, 68, 67-108
11. Hong Y, Eu KW, Seow-Choen F, et al. (2005). GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer, 41, 1037-44
12. Huang WS, Tang R, Lin PY, et al. (2006). Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum, 49, 602-8
13. Jemal A, Siege, R, Xu J, et al. (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300
14. Jiang J, Wang J, Suzuki S, et al. (2006). Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol, 132, 193-9
15. Jing J, Xiong W, Jin H, et al. (2008). Relationship between CCND1 gene A870G polymorphism and genetic susceptibility to colorectal cancer. World Chinese J Digestol, 16, 2553-6
16. Kong S, Amos CI, Luthra R, et al. (2000). Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res, 60, 249-52
17. Kong S, Wei Q, Amos CI, et al. (2001). Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst, 93, 1106-8
18. Kruger S, Engel C, Bier A, et al. (2006). Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett, 236, 191-7
19. Le Marchand L, Seifried A, Lum-Jones A, et al. (2003). Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA, 290, 2843-8
20. Lichtenstein P, Holm NV, Verkasalo PK, et al. (2000). Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343, 78-85
21. Liu B, Parsons R, Papadopoulos N, et al. (1996). Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med, 2, 169-74
22. Liu B, Zhang Y, Jin M, et al. (2010). Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog, 49, 75-84
23. Mantel N and Haenszel W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48
24. McKay JA, Douglas JJ, Ross VG, et al. (2000). Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer, 88, 77-81
25. Munafo MR and Flint J. (2004). Meta-analysis of genetic association studies. Trends Genet, 20, 439-44
26. Palmqvist R, Stenling R, Oberg A, et al. (1998). Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer, 34, 1575-81
27. Porter TR, Richards FM, Houlston RS, et al. (2002). Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene, 21, 1928-33
28. Probst-Hensch NM, Sun CL, Van Den Berg D, et al. (2006). The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-Stransferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis, 27, 2475-82
29. Schernhammer ES, Tranah GJ, Giovannucci E, et al. (2006). Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer, 94, 928-34
30. Solomon DA, Wang Y, Fox SR, et al. (2003). Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem, 278, 30339-47
31. Talseth BA, Ashton KA, Meldrum C, et al. (2008). Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer, 122, 1273-7
32. Tan XL, Nieters A, Kropp S, et al. (2008). The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer, 122, 2573-80
33. Tejpar S and Van Cutsem E. (2002). Molecular and genetic defects in colorectal tumorigenesis. Best Pract Res Clin Gastroenterol, 16, 171-85
34. Wacholder S, Chanock S, Garcia-Closas M, et al. (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst, 96, 434-42
35. Yaylim-Eraltan I, Arikan S, Yildiz Y, et al. (2010). The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res, 30, 2875-80.